EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BACTÉRIAS PRODUTORAS DE KLEBSIELLA PNEUMONIAE CARBAPENEMASE (KPC): IMPACTO CLÍNICO, RESISTÊNCIA ANTIMICROBIANA E ESTRATÉGIAS DE PREVENÇÃO E CONTROLE

Robson Adachi dos Santos

International Integralize Scientific · 01.06.2026 · 6 (59)

DOI: 10.63391/2hsrbv09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Integralize Scientific, online erschienen am 01.06.2026. Verfasst von Robson Adachi dos Santos. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

KPC-producing Enterobacterales should be viewed not only as laboratory findings, but as high-impact drivers of antimicrobial resistance in healthcare settings. This article examines recent literature on the microbiological basis of KPC, its clinical and epidemiological implications, and the institutional measures most consistently associated with transmission control. An applied, exploratory and descriptive integrative review with a qualitative approach was conducted using technical documents and scientific papers published between 2020 and 2025. The corpus included publications from WHO, CDC, ECDC, IDSA and recent studies addressing resistance genetics and therapeutic options for carbapenem-resistant Enterobacterales. The review suggests that dissemination of the blaKPC gene through mobile genetic elements contributes to persistence of multidrug-resistant strains and increases the complexity of hospital care. It also indicates that successful containment depends on combining timely diagnosis, microbiological surveillance, contact precautions, environmental hygiene, interfacility communication and antimicrobial stewardship rather than relying on isolated measures. KPC is therefore best understood as a microbiological, clinical and organizational challenge that requires sustained and coordinated responses.

Zitieren

APA

Santos, R. A. D. (2026). BACTÉRIAS PRODUTORAS DE KLEBSIELLA PNEUMONIAE CARBAPENEMASE (KPC): IMPACTO CLÍNICO, RESISTÊNCIA ANTIMICROBIANA E ESTRATÉGIAS DE PREVENÇÃO E CONTROLE. International Integralize Scientific, 6(59). https://doi.org/10.63391/2hsrbv09

Vancouver

Santos RAD. BACTÉRIAS PRODUTORAS DE KLEBSIELLA PNEUMONIAE CARBAPENEMASE (KPC): IMPACTO CLÍNICO, RESISTÊNCIA ANTIMICROBIANA E ESTRATÉGIAS DE PREVENÇÃO E CONTROLE. International Integralize Scientific. 2026;6(59). doi:10.63391/2hsrbv09

BibTeX
@article{Santos2026,
  author = {Santos, Robson Adachi dos},
  title = {BACTÉRIAS PRODUTORAS DE KLEBSIELLA PNEUMONIAE CARBAPENEMASE (KPC): IMPACTO CLÍNICO, RESISTÊNCIA ANTIMICROBIANA E ESTRATÉGIAS DE PREVENÇÃO E CONTROLE},
  journal = {International Integralize Scientific},
  year = {2026},
  volume = {6},
  number = {59},
  doi = {10.63391/2hsrbv09}
}
Kostenlos starten →